Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Abarca
Sort By
Newest First
Sign in
1 / 1
1 / 1
Agreement
Abarca, Amgen Enter Outcomes-Based Agreement For Repatha® (evolocumab)
Abarca
PR-M02-18-NI-103
Feb 28, 2018
